Effectiveness of Polyherbal Unani Formulation in the treatment of Waram-e-Lawzatayn (Tonsillitis)

A CLINICAL STUDY OF WARAME LAWZATAYN (TONSILLITIS) TO EVALUATE THE EFFICACY OF POLYHERBAL UNANI FORMULATION IN ITS MANAGEMENT - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073250

Enrollment

Registered

2024-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J039- Acute tonsillitis, unspecified

Interventions

Intervention1: Khesanda (Infusion): Patients will be given the study drug, a Polyherbal Unani Formulation in the form of Khesanda (Infusion) 140 ml with 20 ml 0f Sharbat Toot Siyah orally twice daily

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient’s of any sex in the age group between 18 and 50 years. 2. Patients with clinically diagnosed waram-e-lawzatayn Damvi (tonsillitis). 3. Clinical Scoring System; a. Severe- =9 b. Moderate- 4-8 c. Mild- =3

Exclusion criteria

Exclusion criteria: 1. Patient with any complication of tonsillitis. 2. Tonsillitis associated with any other systemic, metabolic or chronic disease. 3. Patient’s unsure about attending schedule regularly.

Design outcomes

Primary

Measure	Time frame
Clinical assessment will be done on the basis of: 1. Reduction in Clinical Scoring System 2. Improvement in Patient Global assessment (PGA) on the basis Visual Analogue ScaleTimepoint: 7, 14 and 21 days	—

Secondary

Measure	Time frame
1. Reduction in Clinical Scoring System 2. VASTimepoint: Week 1, 2 & 3	—

Countries

India

Contacts

Public ContactDr Usamah Ahmad

State Unani Medical College and Hospital

asifhussainusmani@gmail.com7905831926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026